Germany-based venture capital investor 415 Capital has held a first close for its first-time fund, which will focus on businesses producing medical devices and technologies for the treatment of cardiovascular diseases.
Fund has a focus on sectors benefiting from the fourth industrial revolution
Bain & Co's investment was coupled with the recently secured $200m funding from CVC Growth Partners
JC Flowers and Reggeborgh are majority shareholders in the listed Netherlands-based bank
Alex Snodgrass, an investor at BGF, will take a seat on the board of the digital consultancy